Consistency: Consistent. Notes, review YAML and PN agree SPNS1 is a lysosomal proton-driven lysophospholipid (LPC/LPE) efflux transporter, and that "efflux of autophagy products" is biologically plausible. The review explicitly accepts the PN GO:0007041 projection as a NEW annotation and cites the PN mapping file. No contradictions.
PN story / NEW pressure: PN asserts a lysosomal-export role not previously in GOA. GO:0007041 lysosomal transport is verified real (OLS: "movement into/out of/within a lysosome") and is genuinely absent from SPNS1 GOA (confirmed in goa.tsv) — the review correctly adds it as NEW. The review goes further with two proposed_new_terms (lysophospholipid:proton symporter activity; lysosomal lysophospholipid export), the right altitude for the precise cargo/direction the broad GO:0007041 misses. Conclude: ADD GO:0007041 (done as NEW) + proposed_new_terms; defensible.
Mapping strategy: Gene does not change the node; GO:0007041 is appropriately broad (an over-broad "lysosomal transport" is acceptable here as the only fitting current term, and the review flags it as broad). Status/scope correct.
Evidence alignment: Partial overlap. PN cites the Spinster ALR/mTOR PNAS paper and a trafficking review (titles only). Review's core evidence is the direct human/mouse transporter literature (PMID:36161949, 37075117, 39739806, 40608416) — stronger, mechanism-level; the PN ALR/mTOR paper is not in review supported_by but is consistent.
Verdict: Fully consistent; PN projection correctly actioned as NEW. No edits needed.